INS and type 2 diabetes mellitus: Peripheral administration of many T2DM drugs, which act as insulin-sensitizing agents, was often shown to not only reverse central insulin resistance but also to alleviate the associated brain mitochondrial dysfunction and improve respiratory function and redox capacity in the CNS.